Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI – Get Free Report) Director Brett Brodnax bought 35,000 shares of the firm’s stock in a transaction dated Tuesday, May 19th. The shares were acquired at an average price of $7.25 per share, with a total value of $253,750.00. Following the completion of the transaction, the director owned 62,027 shares of the company’s stock, valued at approximately $449,695.75. The trade was a 129.50% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Lumexa Imaging Stock Down 2.2%
NASDAQ:LMRI opened at $8.00 on Friday. Lumexa Imaging Holdings, Inc. has a twelve month low of $6.45 and a twelve month high of $19.45. The stock’s fifty day simple moving average is $9.63.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on LMRI. Raymond James Financial upgraded Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 target price for the company in a research report on Monday, February 9th. Weiss Ratings began coverage on Lumexa Imaging in a research report on Wednesday, May 13th. They set a “sell (e-)” rating for the company. Finally, Barclays decreased their target price on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $16.00.
Institutional Trading of Lumexa Imaging
Several institutional investors and hedge funds have recently made changes to their positions in LMRI. Assetmark Inc. bought a new stake in shares of Lumexa Imaging in the fourth quarter valued at about $36,000. Strs Ohio bought a new stake in shares of Lumexa Imaging in the first quarter valued at about $38,000. PNC Financial Services Group Inc. bought a new stake in shares of Lumexa Imaging in the first quarter valued at about $63,000. State of Wyoming bought a new stake in shares of Lumexa Imaging in the first quarter valued at about $91,000. Finally, Barclays PLC bought a new stake in shares of Lumexa Imaging in the fourth quarter valued at about $133,000.
Lumexa Imaging Company Profile
We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).
Further Reading
- Five stocks we like better than Lumexa Imaging
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Lumexa Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumexa Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
